Home » Newsletters » BioWorld

BioWorld

April 11, 1996

View Archived Issues

CAMBRIDGE BIOTECH SEEKS NEW START WITH REORGANIZATION PLAN

ICOS TO SELL 6M SHARES; STARTS PHASE II STUDY WITH LEAD DRUG

NEUREX REGISTERS TO SELL 3M SHARES TO RAISE $51.4M

HUMAN GENOME PROJECT LAUNCHES FINAL PHASE WITH $18M

TUBBY MOUSE GENE BOWS TWICE, ADDING NOVEL PATHWAY TO MID-LIFE OBESITY